"Hyperprolactinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Descriptor ID |
D006966
|
| MeSH Number(s) |
C10.228.140.617.738.250.450 C19.700.355.600
|
| Concept/Terms |
Hyperprolactinemia- Hyperprolactinemia
- Hyperprolactinemias
- Prolactin, Inappropriate Secretion
- Inappropriate Secretion Prolactin
- Secretion Prolactin, Inappropriate
- Inappropriate Prolactin Secretion Syndrome
- Prolactin Hypersecretion Syndrome
- Hypersecretion Syndrome, Prolactin
- Syndrome, Prolactin Hypersecretion
- Hyperprolactinaemia
- Inappropriate Prolactin Secretion
- Prolactin Secretion, Inappropriate
- Secretion, Inappropriate Prolactin
|
Below are MeSH descriptors whose meaning is more general than "Hyperprolactinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperprolactinemia".
This graph shows the total number of publications written about "Hyperprolactinemia" by people in this website by year, and whether "Hyperprolactinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperprolactinemia" by people in Profiles.
-
Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study. BMC Endocr Disord. 2020 Feb 19; 20(1):25.
-
Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 04; 21(2):190-196.